GSK3A and atherosclerosis: We observed that myeloid-specific GSK3α- and GSK3αβ-deficient Ldlr−/− mice show lower expression of lesional NFκB, NLRP3, and IL-1β compared to controls, correlating with reduced lesion area during atherosclerosis.